BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Genflow Biosciences PLC Launches New Development Program

  April 10, 2025

   · 

  2 min read
• Press Releases

  West to Host First-Quarter 2025 Conference Call

  April 10, 2025

   · 

  1 min read
• Press Releases

  Preliminary results for the year ended 31 December 2024

  April 10, 2025

   · 

  91 min read
• Press Releases

  Gain Therapeutics Presents Additional Preclinical Data and Design of Phase 1b Clinical Study of GT-02287 at AD/PD 2025 and Provides Enrollment Update

  April 10, 2025

   · 

  9 min read
• Press Releases

  Alterome Therapeutics Announces New Chief Executive Officer and Chair of the Board of Directors

  April 10, 2025

   · 

  4 min read
• Press Releases

  Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2025

  April 10, 2025

   · 

  6 min read
• Press Releases

  Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign

  April 10, 2025

   · 

  7 min read
• Press Releases

  Syntis Bio Releases New Data Supporting Potential of SYNT-101 as a Once-Daily Oral Treatment for Obesity at European Congress on Obesity and Weight Management

  April 10, 2025

   · 

  4 min read
• Press Releases

  BriaCell’s Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3

  April 10, 2025

   · 

  5 min read
• Press Releases

  Health Canada approves IMFINZI® (durvalumab) as the first and only immunotherapy regimen for adult patients with limited-stage small cell lung cancer (LS-SCLC)

  April 10, 2025

   · 

  6 min read